1. Home
  2. CRAI vs CADL Comparison

CRAI vs CADL Comparison

Compare CRAI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$170.91

Market Cap

1.2B

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$12.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
CADL
Founded
1965
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CRAI
CADL
Price
$170.91
$12.78
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$245.00
$19.00
AVG Volume (30 Days)
102.8K
1.2M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
58.62
EPS
8.14
N/A
Revenue
$751,583,000.00
$125,000.00
Revenue This Year
$7.82
N/A
Revenue Next Year
$5.14
N/A
P/E Ratio
$21.38
N/A
Revenue Growth
9.33
N/A
52 Week Low
$132.17
$4.35
52 Week High
$227.29
$14.00

Technical Indicators

Market Signals
Indicator
CRAI
CADL
Relative Strength Index (RSI) 53.81 57.84
Support Level $169.92 $4.84
Resistance Level $179.81 $14.00
Average True Range (ATR) 4.40 0.81
MACD -0.35 -0.06
Stochastic Oscillator 63.39 59.17

Price Performance

Historical Comparison
CRAI
CADL

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: